Changzhou Qianhong Bio-Pharma Co.,Ltd.’s Net Profit Rose 129.9% in First Half of 2022

Changzhou Qianhong Bio-Pharma Co.,Ltd. (常州千红生化制药股份有限公司) (002550.SZ) reported a net profit of 195.7 million yuan in the first half of 2022, up 129.9% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 30.2% year-on-year.

At the end of the reporting period, it had 2.6 billion yuan in total assets and 455.1 million yuan in total liabilities, with a liability-to-asset ratio of 17.4%.